Nasal DNA methylation at three CpG sites predicts childhood allergic disease

Merlijn van Breugel, Cancan Qi, Zhongli Xu, Casper Emil T. Pedersen, Ilya Petoukhov, Judith M. Vonk, Ulrike Gehring, Marijn Berg, Marnix Bügel, Orestes A. Carpaij, Erick Forno, Andréanne Morin, Anders U. Eliasen, Yale Jiang, Maarten van den Berge, Martijn C. Nawijn, Yang Li, Wei Chen, Louis J. Bont, Klaus BønnelykkeJuan C. Celedón, Gerard H. Koppelman, Cheng Jian Xu

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

Samenvatting

Childhood allergic diseases, including asthma, rhinitis and eczema, are prevalent conditions that share strong genetic and environmental components. Diagnosis relies on clinical history and measurements of allergen-specific IgE. We hypothesize that a multi-omics model could accurately diagnose childhood allergic disease. We show that nasal DNA methylation has the strongest predictive power to diagnose childhood allergy, surpassing blood DNA methylation, genetic risk scores, and environmental factors. DNA methylation at only three nasal CpG sites classifies allergic disease in Dutch children aged 16 years well, with an area under the curve (AUC) of 0.86. This is replicated in Puerto Rican children aged 9–20 years (AUC 0.82). DNA methylation at these CpGs additionally detects allergic multimorbidity and symptomatic IgE sensitization. Using nasal single-cell RNA-sequencing data, these three CpGs associate with influx of T cells and macrophages that contribute to allergic inflammation. Our study suggests the potential of methylation-based allergy diagnosis.

Originele taal-2Engels
Artikelnummer7415
TijdschriftNature Communications
Volume13
Nummer van het tijdschrift1
DOI's
StatusGepubliceerd - dec. 2022
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'Nasal DNA methylation at three CpG sites predicts childhood allergic disease'. Samen vormen ze een unieke vingerafdruk.

Citeer dit